Riskpilot← Back to searchSign inGet full accessDR Djurfeldt AB
ABActiveOrg 5568820749Hästvretesvägen 6Other education n.e.c. · NACE 8559Est. 20120 employees
Revenue 2024
SEK 104K
+68% vs 2023
EBITDA margin
7.7%
-20% vs 2023
Equity ratio
59.4%
Financial strength
Net profit 2024
SEK 3K
-40% vs 2023
| Revenue | SEK 104K | +68% |
| EBITDA | SEK 8K | -20% |
| Net profit | SEK 3K | -40% |
| Total assets | SEK 106K | -16% |
| Equity | SEK 63K | +5% |
| Employees | 0 | — |
Legal name
DR Djurfeldt AB
Org number
5568820749
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
26 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva utbildning, erbjuda läkartjänster samt lägenhetsuthyrning.
Address
Hästvretesvägen 6
Phone
+46707910999
Email
d.r.djurfeldt@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 143 | 170 | 108 | 62 | 104 |
| Staff expenses | — | — | −76 | — | — |
| EBITDA | 17 | 50 | −235 | 10 | 8 |
| Depreciation & amort. | −4 | −4 | −4 | −4 | −4 |
| EBIT | 13 | 46 | −239 | 6 | 4 |
| Net financials | −21 | −23 | −23 | 1 | 1 |
| Profit before tax | −8 | 16 | −178 | 6 | 5 |
| Tax | −0 | −4 | — | −1 | −2 |
| Net profit | −8 | 12 | −178 | 5 | 3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 978 | 2 011 | 138 | 126 | 106 |
| Equity | 161 | 173 | 55 | 60 | 63 |
| Long-term debt | 672 | 650 | 0 | 0 | 0 |
| Short-term debt | 1 068 | 1 105 | 83 | 66 | 43 |
| Total debt | 1 740 | 1 755 | 83 | 66 | 43 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
59.4%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
4.8%
This company
18.4%
Market median
-74% vs market
20202024
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20202024
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2024 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DR Djurfeldt AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alfred Offrell | Deputy Board Member | 0 companies |
| Sara Hanna Julia Djurfeldt | Deputy Board Member | 0 companies |
| Alexander Radu | Deputy Board Member | 0 companies |
| Diana Pascal | Board of Directors | 0 companies |